Table 2.
miR-30a-5p expression correlated with clinical pathological characteristics (logistic regression).
| Characteristics | Total (N) | Odds Ratio (OR) | P value |
|---|---|---|---|
| T stage (T2&T3&T4 vs. T1) | 996 | 0.530 (0.399-0.701) | <0.001 |
| N stage (N1&N2&N3 vs. N0) | 979 | 0.639 (0.490-0.832) | <0.001 |
| M stage (M1 vs. M0) | 770 | 1.398 (0.663-3.038) | 0.383 |
| Primary therapy outcome (PD&PR vs. SD&CR) | 782 | 0.683 (0.450-1.027) | 0.069 |
| Pathologic stage (Stage III&Stage IV vs. Stage I&Stage II) | 988 | 0.746 (0.543-1.022) | 0.049 |
| Race (White vs. Asian) | 744 | 0.718 (0.258-1.889) | 0.505 |
| Gender (Male vs. Female) | 999 | 0.768 (0.596-0.990) | 0.042 |
| Age (>65 vs. <=65) | 972 | 1.448 (1.123-1.871) | 0.004 |
| Residual tumor (R1&R2 vs. R0) | 752 | 0.633 (0.295-1.309) | 0.225 |
| Smoker (Yes vs. No) | 974 | 0.652 (0.418-1.005) | 0.050 |